NEW YORK (GenomeWeb) – Alere announced today that it has received CE marking for a rapid molecular diagnostic test for HIV 1/2 on its Alere q platform.

The assay is a point of care test that detects and distinguishes between strains of HIV virus in less than 60 minutes, the Waltham, Mass.-based diagnostics firm said in a statement. It will be applied toward early infant diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.